[go: up one dir, main page]

AU2001285102A1 - Adenosine deaminase homolog - Google Patents

Adenosine deaminase homolog

Info

Publication number
AU2001285102A1
AU2001285102A1 AU2001285102A AU8510201A AU2001285102A1 AU 2001285102 A1 AU2001285102 A1 AU 2001285102A1 AU 2001285102 A AU2001285102 A AU 2001285102A AU 8510201 A AU8510201 A AU 8510201A AU 2001285102 A1 AU2001285102 A1 AU 2001285102A1
Authority
AU
Australia
Prior art keywords
adenosine deaminase
homolog
deaminase homolog
adenosine
deaminase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285102A
Inventor
John N. Feder
Gabe Mintier
Chandra Ramanathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2001285102A1 publication Critical patent/AU2001285102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001285102A 2000-08-21 2001-08-20 Adenosine deaminase homolog Abandoned AU2001285102A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22678600P 2000-08-21 2000-08-21
US60/226,786 2000-08-21
US26177801P 2001-01-16 2001-01-16
US60/261,778 2001-01-16
PCT/US2001/025976 WO2002016586A2 (en) 2000-08-21 2001-08-20 Adenosine deaminase homolog

Publications (1)

Publication Number Publication Date
AU2001285102A1 true AU2001285102A1 (en) 2002-03-04

Family

ID=26920882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285102A Abandoned AU2001285102A1 (en) 2000-08-21 2001-08-20 Adenosine deaminase homolog

Country Status (3)

Country Link
US (3) US6706513B2 (en)
AU (1) AU2001285102A1 (en)
WO (1) WO2002016586A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364012A2 (en) * 2000-11-08 2003-11-26 Millennium Pharmaceuticals, Inc. 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
WO2002038743A2 (en) * 2000-11-09 2002-05-16 Glaxo Group Limited Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
DE102016111568A1 (en) * 2016-06-23 2017-12-28 Phenox Gmbh Implant with detachment mechanism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2394039A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002014483A2 (en) 2000-08-15 2002-02-21 Zymogenetics Inc Human adenosine deaminase
WO2002040715A2 (en) 2000-09-05 2002-05-23 Incyte Genomics, Inc. Molecules for disease detection and treatment
AU2001294823A1 (en) 2000-09-29 2002-04-08 Incyte Genomics, Inc. Hydrolases
EP1364012A2 (en) 2000-11-08 2003-11-26 Millennium Pharmaceuticals, Inc. 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
WO2002038743A2 (en) 2000-11-09 2002-05-16 Glaxo Group Limited Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp

Also Published As

Publication number Publication date
WO2002016586A3 (en) 2002-11-07
WO2002016586A2 (en) 2002-02-28
US20020137061A1 (en) 2002-09-26
US6706513B2 (en) 2004-03-16
US20060160128A1 (en) 2006-07-20
US7169596B2 (en) 2007-01-30
US20040132151A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
EP1255764B8 (en) Purine derivatives
AU2001284333A1 (en) Purine derivatives
AU2001249239A1 (en) Shared groups rostering system
AU2001239746A1 (en) Group-browsing system
AU3330700A (en) Novel cytidine deaminase
AU2001260981A1 (en) Aircraft
AUPQ802400A0 (en) Propulsion system
AU2001275762A1 (en) Simulation system
AU5293400A (en) Fair discard system
AU2002344822A1 (en) Thrower system
AU2001259186A1 (en) Ticketless admission system
AU2001284775A1 (en) Anti-balling system
IL152623A0 (en) Attack aircraft
AU2002213429A1 (en) Antiviral methods and compounds
AU2001252758A1 (en) Online relay-broadcasting system
AU2001284902A1 (en) Human adenosine deaminase
AU2001230678A1 (en) Gating system
AU2001238729A1 (en) Helicopter protection system
GB0227601D0 (en) Propulsion system
AU2001285102A1 (en) Adenosine deaminase homolog
AU2001289885A1 (en) Air-preparation system
AU2001295303A1 (en) Fire-fighting system
AU2002224845A1 (en) Viral expression system
AU1042701A (en) Antiviral combinations
AU2001239048A1 (en) Hand protection system